MyFinsight
Home
Blog
About
Maturities of marketable
debt securities
$55,220K
(-59.40%↓ Y/Y)
Sales of marketable
debt securities
$11,465K
Proceeds from sales of
common stock under...
$19,499K
Proceeds from exercise of
stock options
$51K
(-77.63%↓ Y/Y)
Net cash provided by
(used in) investing...
$65,925K
(168.89%↑ Y/Y)
Net cash provided by
financing activities
$17,571K
(-86.83%↓ Y/Y)
Canceled cashflow
$760K
Canceled cashflow
$1,979K
Net increase in cash
and cash...
$21,258K
(-3.51%↓ Y/Y)
Canceled cashflow
$62,238K
Purchases of property and
equipment
$760K
(-46.29%↓ Y/Y)
Net loss
$22,709K
(135.05%↑ Y/Y)
Stock-based compensation
expense
$9,053K
(-47.34%↓ Y/Y)
Non-cash interest
expense
$5,987K
(140.44%↑ Y/Y)
Depreciation and
amortization
$3,757K
(-52.20%↓ Y/Y)
Other current assets
-$2,286K
(-140.87%↓ Y/Y)
Operating lease
right-of-use assets
-$1,674K
(49.36%↑ Y/Y)
Accrued expenses and
other current...
$1,171K
(145.62%↑ Y/Y)
Repayments under royalty
monetization liabilities,...
$1,806K
(-83.36%↓ Y/Y)
Expenses related to
at-the-market offering...
$173K
Net cash used in
operating activities
-$62,238K
(-296.09%↓ Y/Y)
Canceled cashflow
$46,637K
Accounts receivable
$96,714K
(12142.28%↑ Y/Y)
Accounts payable
-$5,288K
(-373.41%↓ Y/Y)
Deferred revenue
-$3,409K
(-109.05%↓ Y/Y)
Operating lease
liabilities
-$2,115K
(51.89%↑ Y/Y)
Net accretion of
discounts on marketable...
$442K
(-81.79%↓ Y/Y)
Other assets
$389K
(118.34%↑ Y/Y)
Prepaid expenses
$361K
(-78.88%↓ Y/Y)
Other liabilities
-$136K
(95.42%↑ Y/Y)
Net realized gain on
investments
$16K
Other non-cash
adjustments
$5K
(141.67%↑ Y/Y)
Back
Back
Cash Flow
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)
source: myfinsight.com